Act Capital Management, LLC Sqz Biotechnologies CO Call Options Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SQZ
# of Institutions
3Shares Held
1.47MCall Options Held
0Put Options Held
0About SQZ Biotechnologies Co
- Ticker SQZ
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,248,600
- Market Cap $1.46M
- Description
- SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...